CORT - Company ID 0001088856
CORCEPT THERAPEUTICS INC (CORT) reported net income of $99.65M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $99.65M | -29.4% |
| FY 2024 | $141.21M | +33.0% |
| FY 2023 | $106.14M | +4.7% |
| FY 2022 | $101.42M | -9.9% |
| FY 2021 | $112.51M | +6.1% |
| FY 2020 | $106.01M | +12.6% |
| FY 2019 | $94.18M | +24.9% |
| FY 2018 | $75.41M | -41.6% |
| FY 2017 |
CORCEPT THERAPEUTICS INC (CORT) reported net income of $99.65M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CORCEPT THERAPEUTICS INC's net income grew from -$32.35M to $99.65M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $129.12M |
| +1486.3% |
| FY 2016 | $8.14M | +227.0% |
| FY 2015 | -$6.41M | +79.6% |
| FY 2014 | -$31.38M | +31.8% |
| FY 2013 | -$46.01M | -20.9% |
| FY 2012 | -$38.05M | -17.6% |
| FY 2011 | -$32.35M | - |